These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9732411)

  • 1. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells.
    Gögelein H; Hartung J; Englert HC; Schölkens BA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1453-64. PubMed ID: 9732411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies.
    Billman GE; Houle MS; Englert HC; Gögelein H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):182-92. PubMed ID: 14722326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.
    Weyermann A; Vollert H; Busch AE; Bleich M; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):374-81. PubMed ID: 15024553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs.
    Billman GE; Englert HC; Schölkens BA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1465-73. PubMed ID: 9732412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IKs channels by HMR 1556.
    Gögelein H; Brüggemann A; Gerlach U; Brendel J; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):480-8. PubMed ID: 11138839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim.
    Krause E; Englert H; Gögelein H
    Pflugers Arch; 1995 Mar; 429(5):625-35. PubMed ID: 7792140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium.
    Nakaya H; Takeda Y; Tohse N; Kanno M
    Br J Pharmacol; 1991 May; 103(1):1019-26. PubMed ID: 1908730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs.
    Wirth KJ; Uhde J; Rosenstein B; Englert HC; Gögelein H; Schölkens BA; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):155-60. PubMed ID: 10685870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of K(ATP) channel modulators on acetylcholine release from guinea-pig isolated atria and small intestine.
    Kilbinger H; Krause A; Mang CF; Englert H; Wirth K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):371-7. PubMed ID: 12012023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion.
    Gögelein H; Ruetten H; Albus U; Englert HC; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):33-41. PubMed ID: 11485036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glimepiride (Hoe490) inhibits the rilmakalim induced decrease in intracellular free calcium and contraction of isolated heart muscle cells from guinea pigs to a lesser extent than glibenclamide.
    Olbrich HG; Müller M; Lindner S; Henke B; Zarse M; Riehle M; Oremek G; Mutschler E
    Int J Cardiol; 1999 Dec; 72(1):53-63. PubMed ID: 10636633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioselective K(ATP) channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureas.
    Englert HC; Gerlach U; Goegelein H; Hartung J; Heitsch H; Mania D; Scheidler S
    J Med Chem; 2001 Mar; 44(7):1085-98. PubMed ID: 11297455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-sensitive potassium channel blocker HMR 1883 reduces mortality and ischemia-associated electrocardiographic changes in pigs with coronary occlusion.
    Wirth KJ; Rosenstein B; Uhde J; Englert HC; Busch AE; Schölkens BA
    J Pharmacol Exp Ther; 1999 Nov; 291(2):474-81. PubMed ID: 10525061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early exposure to hypertonic solution strongly intensifies the effects of K+ channel opener, rilmakalim, in guinea pig ventricular myocytes.
    Kocić I; Hirano Y; Hiraoka M
    Pol J Pharmacol; 2003; 55(6):1159-62. PubMed ID: 14730116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats.
    Wirth KJ; Klaus E; Englert HG; Schölkens BA; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):295-300. PubMed ID: 10543431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
    Vajda S; Baczkó I; Leprán I
    Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098.
    Kääb S; Zwermann L; Barth A; Hinterseer M; Englert HC; Gögelein H; Näbauer M
    Cardiovasc Drugs Ther; 2003; 17(5-6):435-41. PubMed ID: 15107598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOE-234, a second generation K+ channel opener, antagonizes the ATP-dependent gating of cardiac ATP-sensitive K+ channels.
    Terzic A; Jahangir A; Kurachi Y
    J Pharmacol Exp Ther; 1994 Feb; 268(2):818-25. PubMed ID: 8113994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis, pharmacology and physiological role of cardiac K(ATP) channels.
    Gögelein H; Hartung J; Englert HC
    Cell Physiol Biochem; 1999; 9(4-5):227-41. PubMed ID: 10575200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.